Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RIGL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
25 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
154 filers reported a long position in RIGL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $75.9M | 1.9M | +9.7% |
| Soleus Capital Management, L.P. | $72.1M | 1.8M | +18,335% |
| ARMISTICE CAPITAL, LLC | $65.4M | 1.7M | +30.6% |
| STATE STREET CORP | $40.7M | 1M | -7.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.7M | 785.1K | +2.7% |
| AMERICAN CENTURY COMPANIES INC | $29M | 741.7K | +36.2% |
| LSV ASSET MANAGEMENT | $28.2M | 721.7K | +20% |
| ACADIAN ASSET MANAGEMENT LLC | $23.1M | 591.7K | -11.2% |
| D. E. Shaw & Co., Inc. | $21.2M | 542.5K | +21.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $18.9M | 483.2K | +9.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.